Sestrin 2 levels linked to risk of coronary heart disease in type 2 diabetes: BMC Dr. Hiral patel28 July 2022 10:00 AM ISTChina: Serum Sestrin2 maybe have a potential role in the occurrence and development of diabetes with coronary heart disease (CHD) and low levels of...
Time restricted eating during day improves metabolic profile in adults with type 2 diabetes Dr Kartikeya Kohli27 July 2022 11:00 AM ISTResearchers at NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, the Netherlands have found...
The beneficial metabolic effects of time-restricted eating in adults with type 2 diabetes Isra Zaman27 July 2022 9:45 AM ISTA new study published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) finds that following a...
Type 2 diabetes and sleep disorders together increase risk of developing depression Jacinthlyn Sylvia24 July 2022 7:30 PM ISTIn a new study conducted by Ida KimWium-Andersen and team, it was found that individuals with both Type 2 diabetes (T2D) and sleep disorders had the...
Factory-calibrated CGM accurate for diabetics on hemodialysis: Study Medha Baranwal22 July 2022 8:30 PM ISTA factory-calibrated continuous glucose monitor (CGM) appears to be reasonably accurate for individuals on hemodialysis, according to a new...
Efpeglenatide significantly lowers blood sugar and body weight in type 2 diabetes: AMPLITUDE-M trial Medha Baranwal21 July 2022 3:00 PM ISTKorea: Monotherapy with once-weekly efpeglenatide signiifcanly improved blood sugar control and body weight in patients with type 2 diabetes managed...
Overly restrictive salt intake may worsen outcomes for common form of heart failure Isra Zaman20 July 2022 9:30 AM ISTRestricting salt intake is considered a key component of heart failure treatment, but restricting it too much may actually worsen the outcomes for...
Metformin use lowers hepatocellular cancer risk in NAFLD patients with diabetes: Study Medha Baranwal15 July 2022 8:00 PM ISTUSA: The use of metformin may lower the risk of hepatocellular cancer (HCC) in patients with type 2 diabetes and nonalcoholic fatty liver disease...
GLP 1 receptor agonist and insulin combo improves blood sugar, body weight in type 2 diabetes Medha Baranwal14 July 2022 9:00 AM ISTBosnia and Herzegovina: In type 2 diabetes patients treated with premix insulin, switching to IDegLira (a fixed combination of GLP 1 receptor agonist...
Obesity and type 2 diabetes may increase non-vertebral fracture risk in postmenopausal women Medha Baranwal12 July 2022 11:30 AM ISTSpain: Postmenopausal obese women with type 2 diabetes mellitus (T2DM) are at a higher risk of non-vertebral fractures, a recent study published in...
Uptitrating standard dose of teneligliptin fails to improve blood sugar in type 2 diabetes: JAPI Medha Baranwal11 July 2022 12:30 PM ISTMumbai, Maharashtra: Increasing the dose of teneligliptin from 20 to 40 mg at 3 months did not result in statically significant improvement in...
Zydus launches oral solution for type 2 diabetes Roshni Dhar10 July 2022 3:45 PM ISTZydus Lifesciences Ltd., a discovery-driven global lifesciences company has launched the molecule Sitagliptin in India under the brand names Sitaglyn...
